FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral- mediated transduction

Blood

Volumn 89, Issue 2, 1997, Pages 446-456

  Dao, Mo A ^b   Hannum, Charles H ^b   Kohn, Donald B ^b   Nolta, Jan A ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; COLONY FORMING CELL; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031019451     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.446     Document Type: Article

References (46)

1. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
2. Lewis PF, Emerman M: Passage through mitosis is required for oncoretorviruses but not for the human immunodeficiency virus. J Virol 68:510, 1994
3. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529, 1993
4. Cassel A, Cottler-Fox M, Doren S, Dunbar CE: Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
5. Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA: The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long -term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Gene Ther 2:512, 1995
6. Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393, 1992
7. + cells from Gaucher patients. Blood 86:141, 1995
8. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
9. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
10. Lyman SD, James L, Vanden BT, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, Splett RR, Beckmann MP, McKenna HJ: Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
11. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C: Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors/ monocytic precursors. Blood 86:1661, 1995
12. + hematopoietic progenitor cells. Blood 86:3413, 1995
13. Broxmeyer HE, Lu L, Cooper S, Ruggiere L, Li ZH, Lyman SD: Flt3 ligand stimulates/costimulates the growth of myeloid stem/ progenitor cells. Exp Hematol 23:1121, 1995
14. - cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
15. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV: Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220, 1994
16. Nolta JA, Hanley MB, Kohn DB: Sustained human hematopoiesis in immunodeficient mice by co-transplantation of marrow stroma expressing human IL-3: Analysis of gene transduction of long-lived progenitors. Blood 83:3041, 1994
17. Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB: Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA 93:2414, 1996
18. Nolta JA, Yu XJ, Kohn DB: Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest 90:342, 1992
19. Challita PM, Skelton D, El-Khoueiry A, Yu, XJ, Weinberg KI, Kohn DB: Multiple modifications in cis-elements of the LTR of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma (EC) cells. J Virol 69:748, 1995
20. Crooks GM, Kohn DB: Growth factors increase amphotropic retrovirus binding to human CD34 positive bone marrow progenitor cells. Blood 82:3290, 1993
21. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
22. Rill DR, Santana VM, Roberts WM, Nilson T, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
23. v mice. Cell 42:71, 1985
24. Jordan CT, Lemsischka IR: Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 4:220, 1990
25. Keller G, Paige C, Gilboa E, Wagner EF: Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hematopoietic precursors. Nature 318:149, 1985
26. Eglitis MA, Kantoff P, Gilboa E, Anderson WF: Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science 230:1395, 1985
27. Silver J, Keerikatte V: Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J Virol 63:1924, 1989
28. - cells in cord blood and bone marrow. Blood 86:3745, 1995
29. Pietrzyk ME, Priestley GV, Wolf NS: Normal cycling patterns of hematopoietic stem cell subpopulations: An assay using long-term in vivo BrdU infusion. Blood 66:1460, 1985
30. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA. Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
31. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
32. + hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089, 1993
33. Bodine DM, Karlsson S, Neinhuis AW: Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86:8897, 1986
34. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257, 1990
35. Moritz T, Dutt P, Hanenberg H, Xiao X, Ryder J, Carstanien D, Patel V, Vik T, Williams DA: A chymotryptic fragment of fibronectin (FN 30/35) increases gene transfer efficiency via colocalization of target cells and retroviral vectors. Exp Hematol 23:699a, 1995
36. Hannum C, Culpepper J, Campbell D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
37. Jacobsen SW, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The Flt3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
38. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747, 1994
39. + human bone marrow cells and is involved in the proliferation of early stem/ progenitor cells. Proc Natl Acad Sci USA 91:459, 1994
40. Fletcher FA, Moore KA, Ashkenazi M, De Vries P, Overbeek PA, Williams DE, Belmont JW: Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J Exp Med 174:837, 1991
41. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett GA, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfeld MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
42. Dao MA, Nolta JA: Clonal diversity of vector-marked human hematopoietic progenitors recovered from long-term engrafted immune deficient mice. Exp Hematol 24:1056, 1996
43. Emmons RVB, Doren S, Hines K, Carter CS, Cottler-Fox M, O'Shaughnessy JA, Leitman SF, Cowan K, Dunbar CE: Comparison of retroviral transduction conditions for gene marking of adult peripheral blood or marrow-derived CD34+ cells in a clinical trial. Blood 86:940a, 1995 (abstr, suppl 1)
44. Stewart AK, Prince HM, Sutherland DR, Cappe D, Nanji S, Dube ID: Retroviral-mediated gene transfer in multiple myeloma. Blood 86:965a, 1995 (abstr, suppl 1)
45. Hanania EG, Kavanagh J, Giles RE, Kudelka A, Rahman Z, Holmes F, Hortobagyi G, Hamer J, Calvert L, Finnegan MB, Mante R, Ellerson D, Geisler D, Wang T, Su Y, Zu Z, Chen N, Berenson R, Heimfield S, Claxton D, Mechetner E, Holzmayer T, Mehra R, Cote R, Champlin R, Diesseroth AB: Rapid neutrophil recovery in autologous transplants using cells that have been exposed to a multiple drug resistance (MDR-1) retroviral vector. Blood 86:1833a, 1995 (abstr, suppl 1)
46. Hines KA, Cottler-Fox M, Doren S, Carter CS, Dunbar C: Preparation of autologous marrow stromal cells for clinical human gene therapy trials. J Hematother 4:226a, 1995